Optimizing surgical timing following neoadjuvant therapy for gastric Cancer: Insights from a multicenter retrospective analysis
Timely surgery, especially within 4 weeks post-NAT, optimizes survival outcomes, particularly in patients with limited NAT response. This study underscores the need for individualized surgical timing and calls for prospective multicenter validation.
Authors
- Yong Fan
- Jun Kun Lu (ORCID: https://orcid.org/0000-0001-9759-0227)
- Ting Gao (ORCID: https://orcid.org/0000-0002-6981-1886)
- Keshu Hu (ORCID: https://orcid.org/0000-0003-4576-3688)
- Yakai Huang
- Jie Chen (ORCID: https://orcid.org/0000-0002-7712-5982)
- Chen Li (ORCID: https://orcid.org/0000-0002-6895-2759)
- Fenglin Liu (ORCID: https://orcid.org/0000-0003-3617-7126)
- Hongda Pan
- Zhenjia Yu (ORCID: https://orcid.org/0000-0002-3270-6855)
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Fudan University Shanghai Cancer Center (CN)
- Lanzhou University Second Hospital (CN)
- Shanghai Institute of Hematology (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1016/j.ejso.2025.110063
- Citations
- 3
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- National Natural Science Foundation of China